Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLP-1 Receptor Agonists Prevent Alzheimer's Disease Onset, Not Progression: Resolving the Real-World-Randomised Trial Paradox Across Five Continents

NCT07677865 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07677865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07677865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLP-1 Receptor Agonists Prevent Alzheimer's Disease Onset, Not Progression: Resolving the Real-World-Randomised Trial Paradox Across Five Continents
Lead sponsor
West China Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2007
Completion date
June 24, 2026
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, diabetes mellitus type 2, obesity & overweight